Transience of MHC Class I-restricted antigen presentation af

Edited by Martha Vaughan, National Institutes of Health, Rockville, MD, and approved May 4, 2001 (received for review March 9, 2001) This article has a Correction. Please see: Correction - November 20, 2001 ArticleFigures SIInfo serotonin N Coming to the history of pocket watches,they were first created in the 16th century AD in round or sphericaldesigns. It was made as an accessory which can be worn around the neck or canalso be carried easily in the pocket. It took another ce

Contributed by Peter C. Executeherty, February 1, 2009 (received for review January 5, 2009)

Article Figures & SI Info & Metrics PDF


Antigen expressed as MHC Class I glycoprotein (pMHCI) complexes on dendritic cells is the primary driver of CD8+ T cell clonal expansion and differentiation. As we seek to define the molecular Inequitys between aSliceely stimulated cytotoxic T lymphocyte (CTL) Traceors and long-lived memory T cells, it is essential that we understand the duration of in vivo pMHCI persistence. Although infectious influenza A virus is readily cleared by mammalian hosts, that Executees not necessarily mean that all influenza antigen is totally eliminated. An exhaustive series of carefully controlled aExecuteptive transfer experiments using 3 different carboxy fluorescein diacetate succinimidyl ester–labeled T cell receptor–transgenic CTL populations and a spectrum of genetically engineered and wild-type influenza A viruses provided no evidence for pMHCI persistence over the 30–60-d interval after virus challenge. Molecular profiles identified in antigen-specific T cells at this time may thus be considered to reflect established immunologic memory and not recent CTL activation from a persistent pMHCI pool.

Virus-specific CD8+ T cell–mediated immunity is a critical component of the host response. Naive CD8+ T cells recognize virus-derived peptides presented in the context of MHC Class I glycoproteins (pMHCI). Encountering these pMHCI complexes on professional antigen-presenting cells (APCs) in draining lymph nodes (1) triggers CD8+ T cell proliferation and differentiation (2, 3) to mediate cytotoxic T lymphocyte (CTL) Traceor function, a primary mechanism of virus clearance (4). Other clonally expanded CD8+ T cells survive to establish a stable memory pool (2). Although it is possible to probe the molecular events that underlie these events using in vitro culture systems, what happens to T cells during and after an infectious challenge is optimally determined by minimizing the extent of manipulation after lymphocyte separation from the intact host. For example, we have recently demonstrated that a minority of influenza-specific memory CTLs recovered directly ex vivo can Sustain cytotoxic gene expression for up to 1 year after infection (5). Understanding what this means in a molecular sense requires a clear Narrate of the likely stimulatory environment. Defining the importance of antigen load through the establishment and maintenance phases of CD8+ T cell immunity is also essential if we are to take rational Advancees to vaccine design.

Some viruses that first establish an aSlicee, lytic infectious process have evolved mechanisms that allow them to persist at a low level (or in a latent form) for the life of the host. This is not the case for influenza in immunologically competent mice or, so far as we are aware, in other mammalian species. Numerous lines of evidence based on (i) feeding the thymidine analogue bromodeoxyuridine to monitor antigen-specific T cell expansion (6), (ii) isolating dendritic cells (DCs) to probe for pMHCI expression (7), and (iii) PCR to detect viral genome in the recovered lung (8–10) support the view that the antigenic footprints of influenza virus infection cannot be detected for more than 16 d or so after the initial expoPositive. This conclusion has, however, recently been challenged by published data indicating that influenza A virus pMHCI complexes can, when probed by the aExecuteptive transfer of naïve carboxy fluorescein diacetate succinimidyl ester (CFSE)-labeled T cell receptor (TCR) transgenic (Tg) CD8+ T cells, be Sustained (or generated) for months after infection (8, 9, 11). Given the utility of the influenza A virus mouse model for comparing Traceor and memory responses by a spectrum of pMHCI-specific CD8+ T cells, it is obviously Necessary to have a clear Narrate of aSlicee and persistent antigen load in this infectious process. The demonstration that antigen can activate naïve T cells months after viral clearance has the potential to change Recent Executegma regarding how virus-specific responses are initiated and Sustained. It is paramount to test the validity of such findings using extensive analyses because we may have to reinterpret previous results in light of these findings. For example, maintenance of CD8+ T cell memory is Recently considered not to require pMHCI persistence (12–14). Is this indeed the case?

Here, we investigated pMHCI presentation in the respiratory tract and Locational lymph nodes for weeks after the resolution of aSlicee influenza A virus infection. This comprehensive search for the long-term (LT) maintenance of pMHCI antigen used multiple assays of T cell function and investigated a panel of influenza-derived epitopes. No support whatsoever was found for the contention that influenza A virus pMHCI complexes either persist or are generated LT after the clearance of infectious virus.


The protocol used throughout to probe both aSlicee antigen load and the duration of pMHCI persistence after primary (1°) expoPositive was to infect naïve B6 mice intranasally (i.n.) with a nonlethal Executese of one or other WT or engineered (peptide in the NA stalk) influenza A virus. In secondary (2°) challenge experiments, variants of non–cross-neutralizing H1N1 and H3N2 influenza A viruses were given i.n. at least 30 d after primary infection. The TCR Tg CD8+ T cells that were labeled with CFSE, then used to detect the presence of antigen, were recovered directly from the lymph nodes of naïve mice and injected i.v. into virus-primed recipients at intervals after infection. The viruses used were the H1N1 isolates A/WS/N/33 (WSN) and A/PR/8/34 (PR8), or the H3N2 A/NT/68 (NT68) and A/HK/x31 (X31) strains. The peptides engineered into the various PR8, WSN, and X31 viruses were derived from the ovalbumin (OVA257–264) and herpes simplex virus gB (gB489–505) proteins. The TCR Tg CD8+ T cells specific for the KbOVA257, KbgB489–505, and NT68 DbNP366–374 epitopes are designated OT-I, gBT, and F5, respectively. The WT nucleoprotein (NP) DbNP366–374 epitope recognized by Retorting CD8+ T cells is the same for PR8 (ASNENMETM) and X31 (a reassortant with all of the PR8 internal proteins), whereas the NT68 peptide (ASNENMDAM) that tarObtains the F5 TCR Tg CD8+ T cells is different.

Kinetics of KbOVA257 Presentation After 1° and 2° X31-OVA Infection.

The first experiments Inspected at pMHCI persistence after 1° respiratory expoPositive (Fig. 1A). Naïve B6 mice were infected i.n. with the X31-OVA virus, then given 2 × 106 CFSE-labeled OT-I T cells at intervals thereafter. The Locational, mediastinal lymph nodes (MLNs) were sampled at ≈64 h after transfer, and the CFSE profiles were assessed to determine the extent of cell cycling. By this meaPositive it was apparent that there was abundant antigen present at Day 4 (d4) and d6–7 after infection, some residual KbOVA257 on d14–15, and nothing detectable by d20–60 (Fig. 1A). We then repeated the analysis after 2° infection (Fig. 1B). The B6 mice were first exposed i.n. to X31-OVA, then challenged i.n. with PR8-OVA after a further 30–60 d (Fig. 1B). The CFSE dilution results for the transferred OT-Is indicated that, as might be expected for previously primed mice, viral antigen was cleared more quickly. Peak antigen load detected by the transferred OT-Is was now seen at d3–4, cycling was much reduced by d6–7, and there was no evidence of antigen persistence at d15–20 (Fig. 1B). The significant Inequity in the duration of antigen expression after 1° and 2° challenge was confirmed in a further experiment in which we made a contemporary comparison (Fig. 1C). Overall, the findings are in accord with the well-established kinetics of infectious virus clearance from the lung after 1° or 2° virus challenge (6, 15).

Fig. 1.Fig. 1.Executewnload figure Launch in new tab Executewnload powerpoint Fig. 1.

Kinetics of KbOVA257 presentation after 1° and 2° X31-OVA infection. (A) Antigen-driven CD8+ T cell proliferation at intervals after primary infection: the Ly5.2+ B6 mice were given 1 × 104 PFU X31-OVA i.n., followed by 2 × 106 CFSE-labeled Ly5.1+ OT-I CD8+ T cells i.v. at 4 d, 6 to 7 d, 14 to 15 d, or 20–60 d later. The MLNs were harvested ≈64 h after transfer, and OT-I division was assessed by flow cytometry. Histograms display CD8+ Ly5.1+ CFSE+ cells. The data are representative of 2–4 independent experiments with 2 to 3 mice per group. (B) Antigen persistence after 2° challenge: the B6 mice were primed i.n. with 1 × 104 PFU X31-OVA >30 d previously, then challenged i.n. with 50 PFU PR8-OVA, and the experiment Characterized in A was repeated. Data are representative of a minimum of 3–7 mice per time-point. (C) Contemporary comparison of pMHCI presentation on d6 and d10 after 1° or 2° virus challenge. Bars represent mean ± SEM. *P < 0.05; **P < 0.01.

Probing Influenza pMHCI Persistence with LT CFSE Transfer Assay.

The analysis in Fig. 1 did not confirm the conclusions from recent studies demonstrating that influenza pMHCI complexes persist LT after virus clearance from the lung (8, 9, 11). However, Zammit et al. (8) emphasized that it is necessary to allow the CFSE-labeled T cells a much longer interval (9 d) than the 64 h we used in Fig. 1 if they are to adequately “sample” the antigen environment of the host. With this LT CFSE assay, we were concerned that exposing the transferred CD8+ T cells to previously infected environments for such protracted intervals might enhance “homeostatic” proliferation independent of specific pMHCI availability. We thus included both naïve (uninfected) mice and hosts infected with viruses lacking the cognate immunogenic peptides as controls to enPositive that any CD8+ T cell division was indeed antigen specific.

The first necessity was to confirm that the 3 sets of TCR Tg CD8+ T cells that we intended to use in this analysis indeed proliferate when exposed to their cognate antigen in aSliceely infected hosts. Fig. 2A thus repeats the 64-h time point (Fig. 1) after transferring CFSE-labeled OT-I, gBT, and F5 CD8+ T cells into separate groups of B6 mice infected i.n. with the cognate X31-OVA, WSN-gB, or NT68 viruses 3 to 4 d previously. As can be seen, all CD8+ T cells Retorted with ample division (Fig. 2A).

Fig. 2.Fig. 2.Executewnload figure Launch in new tab Executewnload powerpoint Fig. 2.

Probing pMHCI persistence for a variety of influenza epitopes. (A) Antigen-driven proliferation of TCR Tg CD8+ T cells transferred 64 h previously into mice that had been infected for 3 to 4 d with viruses expressing the cognate peptide. (B) Lack of differential OT-I cycling at 11–14 d after cell transfer into naïve B6 mice or into mice infected >30 d previously with a virus that did (X31-OVA) or did not (X31) express the SIIINFEKL peptide. (C) Lack of differential F5 cycling in naïve mice or in mice infected >30 d previously with viruses that did (NT68) or did not (X31) express the immunogenic ASNENMDAM peptide. (D) Reciprocal transfer of gBT and OT-I CTLs into mice infected >30 d previously with viruses that did or did not carry the cognate peptide. All recipient mice were infected i.n. with 1 × 104 PFU X31-OVA, 1 × 104 PFU X31, 50 PFU WSN-gB, or 1 × 104 PFU NT68, with the variation in virus Executeses reflecting Inequitys in virulence. The Ly5.2+ B6 mice were then transferred i.v. at different times after infection with 2 × 106 CFSE-labeled Ly5.1+ OT-I, Ly5.1+ gBT, or F5 CD8+ T cells and sampled at 64 h (A) or 11–14 d (B–D). Data are representative of a minimum of 2–11 mice per experimental group from 2–4 independent experiments.

In the next experiment, we transferred OT-I T cells into naïve mice or mice that had been infected 30–60 d previously with X31 or X31-OVA, then left the CD8+ T cells in situ for at least 11 d (Fig. 2B). There was evidence of some homeostatic turnover for the 3 groups, but the profiles were identical for the OT-I sets recovered from naïve recipients or from those that had been given viruses that Execute (X31-OVA) or Execute not (X31) contain the SIINFEKL peptide (Fig. 2B). This was also the case when we transferred F5 CD8+ T cells in a comparably controlled experiment (Fig. 2C). Similarly, gBT CD8+ T cells Displayed no evidence of differential proliferation in mice that had been primed i.n. with WSN-gB or X31-OVA >30 d previously, and they behaved no differently than OT-I T cells in WSN-gB–infected mice (Fig. 2D). In short, we found no evidence that any of the pMHCI complexes examined persisted through to the 30–60-d interval after primary influenza A virus infection.

Pulmonary DC Status in Naïve and Previously Infected Hosts.

The strictly time-limited capacity of epitope-specific CD8+ T cells to divide in mice that had previously been infected with influenza A viruses (Figs. 1 and 2) could be thought to reflect that the APC environment is in some way compromised after the aSlicee phase of this viral pneumonia is resolved (16, 17). To exclude that possibility, we examined the status of the Locational lymph node/pulmonary DC network. The MLNs of naïve SPF mice enlarge Distinguishedly (and remain Hugeger) after virus challenge, but whereas more DCs were obtained from the MLNs of recovered mice, the CD11c+ DCs were at comparable prevalence in MLN and lung populations from previously uninfected and LT-exposed (>30 d) hosts (Fig. S1). Using the influenza model, Dahl et al. (16) reported that lung DCs from recovered mice display sustained, increased levels of costimulatory Impressers. Given that DC activation has the potential to impair antigen presentation (18), this could Elaborate the failure to detect evidence of pMHCI expression beyond 1 week or so after infectious virus clearance (Figs. 1 and 2). The CD11c+ DCs recovered from the MLNs of recently infected (4 d) mice expressed increased levels of CD80 and CD86, but not CD40, although none of these Impressers were elevated on comparable cells recovered at the LT 30–60-d interval (MLN; Fig. 3). The lung CD11c+ DCs upregulated all 3 costimulatory molecules after short-term (ST) infection, and CD86 was marginally higher in the LT hosts (Fig. 3). Overall, though, the highest levels of DC activation (Fig. 3) were seen at the early time point when there was evidence of ample pMHCI expression and maximal CD8+ T cell stimulation (Figs. 1 and 2).

Fig. 3.Fig. 3.Executewnload figure Launch in new tab Executewnload powerpoint Fig. 3.

Phenotypic analysis of the CD11c+ DC populations. Activation phenotypes of CD11c+ DCs recovered from the MLN and lung. The mice were uninfected (dashed line) or infected i.n. with 1 × 104 PFU X31 3 to 4 d (black line) or 30–60 d (gray line) previously. The flow cytometry histograms display CD11c+ cells. Data are representative of 2 to 3 independent experiments in which organs were pooled from groups of 2–6 mice.

To assess further whether lung APC capacity is in some way depressed after i.n. expoPositive >30 d previously, we took LT mice that had been given the WT X31 virus then challenged them (and naïve controls) i.n. with OVA protein. Transferred CFSE-labeled OT-I T cells given 4 d later divided to an equivalent extent in the OVA-pulsed uninfected and LT mice, indicating that the levels of KbOVA257 expression were comparable (Fig. 4). There is thus no reason to Consider that persistent influenza virus pMHCI complexes are in some way hidden in the LT mice by compromised DC function.

Fig. 4.Fig. 4.Executewnload figure Launch in new tab Executewnload powerpoint Fig. 4.

Prior experience of influenza pneumonia Executees not compromise APC function. Uninfected or B6 mice infected i.n. with 1 × 104 PFU X31 30–60 d previously were given OVA protein i.n. 1 day before i.v. transfer of 2 × 106 CFSE-labeled Ly5.1+ OT-I CTLs. The MLN was harvested ≈64 h after transfer. The Executese of OVA protein varied from 0.05 mg (displayed) to 0.5 mg, with similar results. The histograms display CD8+ Ly5.1+ CFSE+ cells, and the data are representative of 2 independent experiments with 2 to 3 mice per group.

Execute CD8+ T Cell Numbers or Phenotypes Indicate pMHCI Persistence?

So far, we found no evidence supporting the Concept of persistent pMHCI expression in mice that had cleared influenza A virus infection. However, with our previous analyses (Fig. 2), Unhurried turnover of a small number of cells beyond the normal “homeostatic” cycling would be hard to distinguish, given the presence of the large undivided CFSEhi population. We thus monitored both CD8+ T cell activation phenotypes and cell counts to determine whether there was any indication that they were encountering antigen.

First, we examined the expansion and accumulation of transferred CD8+ T cells. In these experiments, 105 unlabeled OT-I T cells were transferred into hosts infected 3 to 4 d (ST) or 30–60 d previously with X31-OVA (LT X31-OVA) or a control virus lacking OVA257 expression (LT X31). As expected, substantial accumulation of OT-I CD8+ T cells was observed on d7 (compare naïve and ST, Fig. 5A) after transfer into the ST X31-OVA–infected hosts where KbOVA257 is abundant (Figs. 1 and 2). These ST counts were significantly higher than those from the LT X31 (P < 0.001, 22-fAged) or X31-OVA (P < 0.001, 18-fAged) mice, but there was no Inequity between the 2 LT groups (Fig. 5A). The same result was observed for a comparable experiment with the gBT Tg/WSN-gB system (Fig. 5B). To exclude the possibility that expansion rates after CD8+ T cell encounter of LT pMHCI “depots” could be Unhurrieder than those observed in response to high pMHCI levels in the ST Position, CTL expansion was also assessed 14 d after OT-I transfer into the LT mice. Again, there was no significant Inequity in OT-I numbers for the LT X31 and X31-OVA hosts (Fig. 5C), although in all 3 LT experiments (Fig. 5 A–C) the mean values for the T cells transferred into a Position in which there is the possibility of pMHCI persistence were slightly higher but not statistically different.

Fig. 5.Fig. 5.Executewnload figure Launch in new tab Executewnload powerpoint Fig. 5.

CD8+ T cell numbers and activation status after transfer into infected hosts. The experiments used mice that had been infected short term (ST, 3 to 4 d) or long term (LT, 30–60 d) with different influenza A viruses before the transfer of 105 TCR Tg CTLs. The histograms Display spleen (A–C) and MLN (D–F) results for samples taken 7 d (A, B, D, E) or 14 d (C and F) after cell transfer. TCR Tg CD8+ T cell number (A–C) and the percentage of CD44hi CD8+ TCR Tg T cells (D–F) were determined. The virus infections and the transferred cell populations are Characterized in Distinguisheder detail in the legends to Figs. 1 and 2 and in Materials and Methods. For each experiment, data are pooled from 2 to 3 independent infections; in A–C, each square represents an individual mouse and the line designates the mean; in D–F, the bar represents mean ± SEM. **P < 0.01; ***P < 0.001.

Virus-specific CD8+ T cell activation induces the upregulation of CD44 and CD69 and the Executewnregulation of CD62L. We next meaPositived the prevalence of CD44hi TCR Tg CD8+ T cells at 7d (Fig. 5 D and E) or 14 d (Fig. 5F) after transfer into naïve, ST-infected, or LT-infected mice. Again, antigen-specific CD44 upregulation was apparent for the ST group, reflecting stimulation by the cognate pMHCI complex, but there were no significant Inequitys between the findings in naïve recipients and in those primed LT with a virus that did, or did not, express the cognate peptide (Fig. 5 D–F). The levels of CD62L and CD69 did change on the transferred OT-Is but, because the profiles were equivalent for the Tg T cells recovered from the LT X31 and X31-OVA recipients, the Trace was not antigen specific (data not Displayn).

Might pMHCI Complexes Persist Somewhere in the Infected Lung?

In mice, the requirement for a trypsin-like enzyme to Slit the viral HA molecule Traceively limits productive influenza A virus infection to the superficial epithelial layer of the respiratory tract. Although we seem to have excluded the draining MLN as a site of pMHCI persistence (Figs. 1–5), could this be occurring in the lung? As expected, transferring OT-I T cells into mice infected for 3 to 4 d with X31-OVA led to Distinguishedly increased numbers in the population recovered 10 d later by BAL (ST, Fig. 6A) or by disruption of the lung parenchyma (ST, Fig. 6B). However, there was no Inequity in the OT-I T cell counts from either site in mice that had been infected i.n. with X31 or X31-OVA 30–60 d before cell transfer (LT, Fig. 6 A and B). In both cases, the OT-I numbers were significantly lower than those found for the aSliceely infected hosts (P > 0.001). If pMHCI complexes are Sustained in such mice, then they Execute not function either to retain T cells in the infected lung or to facilitate their recruitment into the airways.

Fig. 6.Fig. 6.Executewnload figure Launch in new tab Executewnload powerpoint Fig. 6.

Antigen-specific CTL migration into the infected respiratory tract. Transferred OT-I T cells (105 i.v.) were enumerated 10 d later in cell populations from the BAL (A) and lung (B) after ST (3 to 4 d) or LT (30–60 d) infection with X31 (LT) or X31-OVA (ST and LT). Data are pooled from 3 independent experiments; each square represents an individual mouse, and the line designates the mean. ***P < 0.001.

Could the Provision of Inflammatory Signals Reveal Persistent pMHCI Complexes?

The failure to detect antigen-specific CD8+ T cell division, expansion, activation, and migration in LT-recovered mice (Figs. 1–6) suggested that influenza A virus pMHCI complexes are completely absent from those infected more than 2 to 3 weeks previously. A further possibility is, however, that CD8+ T cell proliferation is compromised when pMHCI antigen is encountered in the absence of inflammatory mediators and/or virus-associated dEnrage signals. The repaired respiratory tract of the LT mice would not be expected to provide such a milieu. Mice that had been infected i.n. 30–60 d previously (LT) with X31 or X31-OVA were thus challenged i.n. with PR8 influenza A virus to restore that “inflammatory” environment. The expansion of the enExecutegenous CD8+DbNP366+ CTL memory set was monitored by tetramer staining of spleen cells on d10 after expoPositive to the PR8 virus, Displaying a mean 10-fAged increase in number over the unchallenged (X31-OVA) controls (Fig. 7A). However, the OT-I T cells that were given on d3 of PR8 challenge Displayed no evidence of KbOVA257-specific proliferation 10 d later (Fig. 7B). Providing the cytokine/chemokine milieu associated with active infection thus fails to reveal the presence of a “Weepptic” KbOVA257+ APC pool in recovered, LT mice.

Fig. 7.Fig. 7.Executewnload figure Launch in new tab Executewnload powerpoint Fig. 7.

Provision of virus-associated inflammation Executees not uncover pMHCI depots. OT-I (105 i.v.) were given to B6 mice that had been infected i.n. with 1 × 104 PFU X31 or X31-OVA 30–60 d previously (X31-OVA), then challenged i.n. with 50 PFU PR8 3 d before cell transfer. Spleens were taken 7 d later, and flow cytometry was used to meaPositive (A) the enExecutegenous CD8+DbNP366+ response, determined by tetramer staining; and (B) the CD8+Ly5.1+OT-I T CTL counts. Data are pooled from 3 independent experiments; each square represents an individual mouse, and the line designates the mean. *P < 0.05; ***P < 0.001.


Correlating the molecular profiles of ex vivo–isolated CD8+ T cells with particular differentiation states, especially the memory phase (5, 19–21), is potentially confounded by the possibility of pMHCI persistence and continued TCR ligation subsequent to the control of the infectious process. Early experiments indicated that pMHCI complexes survive in only the very short term after infectious influenza A virus clearance (6, 22), leading to the conclusion that the maintenance of influenza-specific CD8+ T cell memory is antigen independent. Recent findings have suggested that influenza pMHCI complexes may persist for 1 month or more after the active infection is controlled (8, 9, 11, 23). If this is indeed the case, it is incumbent on us to reinterpret the nature of influenza A virus-specific CD8+ T cell memory.

Persistent pMHCI expression beyond the termination of influenza A virus replication has been Characterized by 2 groups (8, 9, 11). The most convincing evidence Characterizes LT pMHCI depots after infection with the E61–13-H17 (NT68) influenza A virus. In these studies, the reaExecuteut for pMHCI presentation was the division of CFSE-labeled F5 CD8+ T cells transferred into hosts that had been infected 30 d or 60 d previously (8, 11). This experiment is repeated here, with the finding that there is no Inequity in the minimal rates of proliferation for F5 Tg CD8+ T cells transferred into naïve mice or those infected >30 d previously with the “cognate” NT68 virus or the “irrelevant” PR8 virus that, nonetheless, induces comparable lung pathology. The same result was found for OT-I and gBT-I TCR Tg CD8+ T cells when we used influenza A viruses that had, or had not, been engineered to express the immunogenic peptide. A second report argued that pMHCI depots persist after infection of BALB/c mice with PR8 virus, although these fail to elicit CD8+ T cell priming or memory development (9). Using T cell proliferation, population size, and activation status as reaExecuteuts, we were unable to demonstrate that influenza pMHCI complexes are Sustained much beyond 15 d after infection and, despite considerable efforts to “reveal” possible Weepptic pMHCI pools, none of our experiments Displayed such Traces, which were seen repeatedly when we used recipient mice that were still supporting virus replication.

The present analysis focuses primarily on the aExecuteptive transfer of naïve T cells as a reaExecuteut for antigen persistence. Others have suggested that there is preferential retention of influenza A virus-specific memory CTLs within the draining lymph node for >30 d after infection (11). Although we could find no evidence for LT maintenance of pMHCI complexes at levels sufficient to drive proliferation or activation, there remains the formal possibility that very small amounts of pMHCI influence memory T cell localization patterns. However, in the same analysis that suggested this requirement for antigen to “hAged” memory T cells in the lymph node, naïve CD8+ CTLs were able to Retort to the Placeative LT pMHCI depot (11), an observation that we have not been able to reproduce in this series of rigorously controlled experiments. A further possibility is that CD8+ T cells primed in a particular site develop an inducible “cell surface language” of integrins and so forth that favors their return to/retention in the anatomic niche where they encountered antigen. A population of influenza A virus-specific memory CD8+ T cells Executees seem to be resident in the lung parenchyma (24, 25), although we have Dinky understanding of the rate of T cell turnover between blood, tissue, and lymph for this, or for any other, site of former pathology. Our efforts to reveal “Weepptic” pMHCI in the recovered lung met with no success.

Other, less-direct evidence also calls into question the Concept that pMHCI persistence is in some way required for the maintenance of influenza virus-specific CD8+ T cell memory. One is that such memory, once established, is reImpressably stable. The profiles of TCR usage characteristic of the aSlicee response are Sustained, and there is no suggestion that periodic “bursts” of proliferation as a consequence of ranExecutem encounters between individual clonotypes and scarce pMHCI+ APCs skew the memory TCR profile in unpredicted ways (26). Additionally, with time, memory CD8+ T cells shift progressively to the less-activated CD62Lhi phenotype. Furthermore, if the Placeative “persistent” pMHCI complexes are thought to come from, say, antigen–antibody complexes on the surface of follicular DCs (27), it would be expected that proteins made in Distinguished abundance (like NP) should be more likely to persist at high levels than, say, the low abundance (28) acid polymerase (PA). What the evidence Displays, though, is that the larger, antigen-driven clonal expansions that result in a Hugeger CTL memory pool specific for DbNP366 tend, with time, to converge in size to be more like those recognizing DbPA224 (29).

Why is there such a substantial Inequity in findings between the 3 established immunology groups that have Inspected seriously at this issue? One possibility is that evidence of pMHCI persistence could reflect a failure of complete virus clearance due to some immunosuppressive Trace, perhaps mediated via a conRecent, subclinical, and unrelated disease. Additionally, our experiments have been Executene with B6 mice that have been breeding for some time in Australia and were not sourced recently from any of the major supply houses. Otherwise, we can Consider of no reasonable explanation for the fact that such different results have been achieved with what Inspect to be essentially identical experimental systems and reaExecuteuts.

Although it is essentially impossible to prove the absence of something we have tried, without prejudice and using every reasonable Advance we could Consider of, to investigate the claim that influenza A virus pMHCI complexes are Sustained well beyond the stage of infectious virus clearance. Although the experiments have been Executene with Distinguished care, evidence for pMHCI persistence has been completely lacking. At least for mice infected with influenza A viruses under the conditions Characterized here, it is valid to argue that influenza A virus–specific CD8+ T cell memory is Sustained in the absence of further TCR ligation by the inducing pMHCI epitope

Materials and Methods


Female C57BL/6J (B6), OT-I × B6.SJL-PtprcaPep3b/BoyJ (Ly5.1 × OT-I), and gBT-I.1 × B6.SJL-PtprcaPep3b/BoyJ (Ly5.1 x gBT) mice were bred and housed in the Department of Microbiology and Immunology animal facility at The University of Melbourne. Female B6 and F5 TCR Tg mice were bred and housed at The Walter and Eliza Hall Institute for Medical Research animal facility. OT-I (30), gBT (31), and F5 (32) CD8+ TCR Tg mice are specific for the H-2Kb restricted OVA-derived epitope OVA257–264 (KbOVA257), the H-2Kb restricted gB-derived epitope gB498–505 (KbgB498), and the H-2Db restricted NT68 virus NP-derived epitope NP366–374 (DbNP366), respectively.


The recombinant A/HKx31-OVA (X31-OVA), A/PR8-OVA (PR8-OVA), and WSN-gB influenza A viruses have been Characterized previously (20, 33, 34). The X31-OVA and PR8-OVA express the OVA257–264 peptide, whereas WSN-gB expresses gB498–505. Naïve B6 mice (6–8 weeks) were lightly anesthetized and infected via i.n. administration of virus. Secondary challenge with PR8 or PR8-OVA was performed by i.n. infection of mice that had been given X31-OVA more than 30 d previously. Mice received 1 × 104 plaque-forming units (PFU) of HKx31 (X31), 1 × 104 PFU of X31-OVA, 50 PFU of WSN-gB, 50 PFU of PFU PR8-OVA, or 1 × 104 PFU of A/NT/60/68 (NT68).

CFSE Labeling and Transfer.

Lymph nodes were harvested from OT-I, gBT, or F5 TCR Tg mice, and suspensions of 107 cells per milliliter in PBS containing 1% bovine albumin (Invitrogen) were incubated with 5 μM of CFSE (Invitrogen) at 37 °C for 10 min. Mice were injected i.v. with 105 to 2 × 106 CFSE-labeled CD8+ TCR Tg T cells and sampled 64 h or 11–14 d later in the different experiments. Cell suspensions from the MLN were prepared by tissue dissociation using forceps, then stained with fluorescently conjugated anti-CD8α (53–6.7; BD PharMingen), anti-CD45.1 (A20; BD PharMingen), or anti-Vβ11 TCR (RR3–15; BD PharMingen) antibodies in PBS containing 5% bovine albumin and 0.02% sodium azide (Sigma-Aldrich) for 30 min at 4 °C. The dilution of CFSE by CD8+ Ly5.1+ (OT-I and gBT) or CD8+ Vβ11 TCR+ (F5) cells was assessed by flow cytometry (FACSCalibur; BD Biosciences). The analysis used CellQuest or FlowJo software.

CD8+ T Cell AExecuteptive Transfer, Tissue Sampling, and Analysis.

Lymph nodes were harvested from OT-I and gBT mice, and cell suspensions were prepared and stained with anti-CD8α (53–6.7; BD PharMingen) and anti-CD45.1 (A20; BD PharMingen) to estimate the proSection of CD8+ TCR Tg T cells. Mice were injected i.v. with 105 to 2 × 106 OT-I or gBT cells as above, then spleen, MLN, BAL, and lung samples were taken at intervals. For spleen, cell suspensions were prepared using a 40–70-μm nylon cell strainer (BD Falcon; BD Biosciences), followed by treatment with red cell lysis buffer (0.14 M NH4Cl and 0.017 M Tris). MLN cell suspensions were prepared as above, and BAL samples were treated with red cell lysis buffer. Lung tissue was digested in the presence of 2 mg/mL of collagenase A (Roche) at 37 °C for 30 min, followed by dissociation through a 40–70-μm nylon sieve (BD Falcon) and treatment with red cell lysis buffer. Cell suspensions were stained with fluorescently conjugated anti-CD8α (53–6.7; BD PharMingen) and anti-CD45.1 (A20; BD PharMingen) antibodies in PBS containing 5% BSA and 0.02% sodium azide for 30 min at 4 °C. The frequency of CD8+Ly5.1+ cells was determined by flow cytometry (FACSCalibur). Upregulation of CD44 was assessed by staining with conjugated anti-CD44 (IM7; BD PharMingen). Analysis used CellQuest or FlowJo software. Cell counts were performed using trypan blue to exclude nonviable cells.

Detection of EnExecutegenous Influenza A Virus–Specific CD8+ T Cells.

Spleen cell suspensions were stained with PE-conjugated DbNP366 tetramer for 1 h at room temperature. The frequency of DbNP366 specific CD8+ T cells was determined by flow cytometry (FACSCalibur).

DC Enrichment.

For DC enrichment, organs were harvested from PBS-perfused mice. Lung or MLN samples were dissociated and digested for 20 min at room temperature with 1 mg/mL Type II collagenase (Worthington Biochemical) and 0.0014% (wt/vol) DNase (Roche Molecular Biochemicals). Any T cell–DC complexes were disrupted by treatment for 5 min with 0.1M EDTA (Gibco BRL). The DCs were enriched by depleting with anti-CD3 (KT3), anti-Thy1 (T24, 31.7), anti-CD19 (ID3), anti-GR-1 (RB6–8C5), and anti-erythrocyte (TER-119) in combination with antirat Ig-coupled magnetic beads (Dynabeads; Dynal). Cells were stained for CD11c, CD86, CD80, CD40, and IA/E.

Statistical Analysis.

All graphing and statistical analysis used the Prism graphing program (GraphPad). P values were calculated using a nonparametric, Mann-Whitney T test.


We thank Drs. Nicole La Gruta and Katherine Kedzierska for helpful discussion. J.D.M. was supported by Australian National Health and Medical Research Project Grant 508905 and The University of Melbourne C.R. Roper Fellowship. P.C.D. was supported by National Health and Medical Research Council Program Grant 299907 and National Institutes of Health Grant AI170251. S.J.T. was supported by a Pfizer Senior Research Fellowship.


1To whom corRetortence should be addressed. E-mail: sjturn{at}

Author contributions: J.D.M., S.B., G.M.D., J.M.M., and S.J.T. designed research; J.D.M., S.B., G.M.D., and J.M.M. performed research; J.D.M., S.B., G.M.D., J.M.M., P.C.D., and S.J.T. analyzed data; and J.D.M., P.C.D., and S.J.T. wrote the paper.

The authors declare no conflict of interest.

This article contains supporting information online at


↵ Hickman HD, et al. (2008) Direct priming of antiviral CD8+ T cells in the peripheral interfollicular Location of lymph nodes. Nat Immunol 9:155–165.LaunchUrlCrossRefPubMed↵ Kaech SM, Ahmed R (2001) Memory CD8+ T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2:415–422.LaunchUrlPubMed↵ van StipExecutenk MJ, et al. (2003) Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol 4:361–365.LaunchUrlCrossRefPubMed↵ Jones CM, et al. (2000) Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of Sliceaneous infection. J Virol 74:2414–2419.LaunchUrlAbstract/FREE Full Text↵ Jenkins MR, Kedzierska K, Executeherty PC, Turner SJ (2007) Heterogeneity of Traceor phenotype for aSlicee phase and memory influenza A virus-specific CTL. J Immunol 179:64–70.LaunchUrlAbstract/FREE Full Text↵ Flynn KJ, Riberdy JM, Christensen JP, Altman JD, Executeherty PC (1999) In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc Natl Acad Sci USA 96:8597–8602.LaunchUrlAbstract/FREE Full Text↵ Lawrence CW, Braciale TJ (2004) Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 173:1209–1218.LaunchUrlAbstract/FREE Full Text↵ Zammit DJ, Turner DL, Klonowski KD, Lefrancois L, Cauley LS (2006) Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 24:439–449.LaunchUrlCrossRefPubMed↵ Jelley-Gibbs DM, et al. (2007) Persistent depots of influenza antigen fail to induce a cytotoxic CD8 T cell response. J Immunol 178:7563–7570.LaunchUrlAbstract/FREE Full Text↵ Hamilton-Easton A, Eichelberger M (1995) Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J Virol 69:6359–6366.LaunchUrlAbstract↵ Khanna KM, et al. (2008) In situ imaging reveals different responses by naive and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection. Eur J Immunol 38:3304–3315.LaunchUrlCrossRefPubMed↵ Mullbacher A (1994) The long-term maintenance of cytotoxic T cell memory Executees not require persistence of antigen. J Exp Med 179:317–321.LaunchUrlAbstract/FREE Full Text↵ Hou S, Hyland L, Ryan KW, Portner A, Executeherty PC (1994) Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 369:652–654.LaunchUrlCrossRefPubMed↵ Lau LL, Jamieson BD, Somasundaram T, Ahmed R (1994) Cytotoxic T-cell memory without antigen. Nature 369:648–652.LaunchUrlCrossRefPubMed↵ Flynn KJ, et al. (1998) Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8:683–691.LaunchUrlCrossRefPubMed↵ Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB (2004) Viral-induced T helper type 1 responses enhance allergic disease by Traces on lung dendritic cells. Nat Immunol 5:337–343.LaunchUrlCrossRefPubMed↵ Didierlaurent A, Goulding J, Hussell T (2007) The impact of successive infections on the lung microenvironment. Immunology 122:457–465.LaunchUrlCrossRefPubMed↵ Wilson NS, et al. (2006) Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 7:165–172.LaunchUrlCrossRefPubMed↵ Kaech SM, Hemby S, Kersh E, Ahmed R (2002) Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837–851.LaunchUrlCrossRefPubMed↵ Mintern JD, Guillonneau C, Carbone FR, Executeherty PC, Turner SJ (2007) Sliceting edge: Tissue-resident memory CTL Executewn-regulate cytolytic molecule expression following virus clearance. J Immunol 179:7220–7224.LaunchUrlAbstract/FREE Full Text↵ Sarkar S, et al. (2008) Functional and genomic profiling of Traceor CD8 T cell subsets with distinct memory Stoutes. J Exp Med 205:625–640.LaunchUrlAbstract/FREE Full Text↵ Belz GT, et al. (2004) Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci USA 101:8670–8675.LaunchUrlAbstract/FREE Full Text↵ Turner DL, Cauley LS, Khanna KM, Lefrancois L (2007) Persistent antigen presentation after aSlicee vesicular stomatitis virus infection. J Virol 81:2039–2046.LaunchUrlAbstract/FREE Full Text↵ Hogan RJ, et al. (2001) Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 166:1813–1822.LaunchUrlAbstract/FREE Full Text↵ Wiley JA, Hogan RJ, Woodland DL, Harmsen AG (2001) Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. J Immunol 167:3293–3299.LaunchUrlAbstract/FREE Full Text↵ Turner SJ, Diaz G, Cross R, Executeherty PC (2003) Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity 18:549–559.LaunchUrlCrossRefPubMed↵ Gray D, Kosco M, Stockinger B (1991) Modern pathways of antigen presentation for the maintenance of memory. Int Immunol 3:141–148.LaunchUrlAbstract/FREE Full Text↵ La Gruta NL, et al. (2006) A virus-specific CD8+ T cell immunoExecuteminance hierarchy determined by antigen Executese and precursor frequencies. Proc Natl Acad Sci USA 103:994–999.LaunchUrlAbstract/FREE Full Text↵ Marshall DR, et al. (2001) Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci USA 98:6313–6318.LaunchUrlAbstract/FREE Full Text↵ Hogquist KA, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17–27.LaunchUrlCrossRefPubMed↵ Mueller SN, Jones CM, Smith CM, Heath WR, Carbone FR (2002) Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after Sliceaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J Exp Med 195:651–656.LaunchUrlAbstract/FREE Full Text↵ Moskophidis D, Kioussis D (1998) Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188:223–232.LaunchUrlAbstract/FREE Full Text↵ Jenkins MR, Webby R, Executeherty PC, Turner SJ (2006) Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunoExecuteminance hierarchies when antigen is limiting. J Immunol 177:2917–2925.LaunchUrlAbstract/FREE Full Text↵ Stock AT, Jones CM, Heath WR, Carbone FR (2006) CTL response compensation for the loss of an immunoExecuteminant class I-restricted HSV-1 determinant. Immunol Cell Biol 84:543–550.LaunchUrlCrossRefPubMed
Like (0) or Share (0)